stoxline Quote Chart Rank Option Currency Glossary
  
DSS, Inc. (DSS)
1.0025  -0.048 (-4.52%)    01-16 15:45
Open: 1.01
High: 1.04
Volume: 8,173
  
Pre. Close: 1.05
Low: 0.98
Market Cap: 9(M)
Technical analysis
2026-01-16 4:47:33 PM
Short term     
Mid term     
Targets 6-month :  1.26 1-year :  1.47
Resists First :  1.08 Second :  1.26
Pivot price 0.98
Supports First :  0.9 Second :  0.8
MAs MA(5) :  1.01 MA(20) :  0.97
MA(100) :  1.17 MA(250) :  1.01
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  76.7 D(3) :  75.5
RSI RSI(14): 48
52-week High :  1.89 Low :  0.72
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ DSS ] has closed below upper band by 48.1%. Bollinger Bands are 52.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 30 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 1.04 - 1.05 1.05 - 1.05
Low: 0.97 - 0.97 0.97 - 0.98
Close: 0.98 - 0.99 0.99 - 1
Company Description

DSS, Inc. operates in the product packaging, biotechnology, direct, commercial lending, securities and investment management, alternative trading, digital transformation, secure living, and alternative energy businesses worldwide. It manufactures, markets, and sells custom folding cartons, mailers, photo sleeves, and 3-dimensional direct mail solutions; and markets and distributes nutritional and personal care products. The company also invests in or acquires companies in the biohealth and biomedical fields, including businesses that focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases; and develops open-air defense initiatives for air-borne infectious diseases comprising tuberculosis and influenza. In addition, it focuses on acquiring equity positions in undervalued commercial banks, bank holding companies, and nonbanking licensed financial companies; and companies engaged in—nonbanking activities related to banking, including loan syndication services, mortgage banking, trust and escrow services, banking technology, loan servicing, equipment leasing, problem asset management, special purpose acquisition company consulting, and advisory capital raising services. Further, the company provides securities and investment management services, as well as operates a real estate investment trust for acquiring hospitals and other acute or post-acute care centers; and focuses on developing healthy living communities. Additionally, it develops and/or acquires assets and investments in the securities trading and/or funds management arena, as well as operates as a digital assets broker dealer; and offers solar farms, solar battery banks, and residential energy creation and storage services. The company was formerly known as Document Security Systems, Inc. and changed its name to DSS, Inc. in September 2021. DSS, Inc. was incorporated in 1984 and is headquartered in West Henrietta, New York.

Headline News

Sat, 10 Jan 2026
Why DSS Inc. stock could see breakout soon - Swing Trade & Daily Technical Forecast Reports - Улправда

Wed, 27 Aug 2025
DSS: Dramatic Stock Leap – Time to Join In? - timothysykes.com

Wed, 27 Aug 2025
Stocks to Watch Today : Nvidia, CrowdStrike, DSS Inc., NovaBay Pharma, Kohl’s Corporation - Eurasia Business News

Wed, 27 Aug 2025
DSS Stock Surges Amid Strategic Moves and Market Reactions - StocksToTrade

Tue, 24 Jun 2025
DSS subsidiary Impact BioMedical to merge with Dr. Ashleys - Investing.com

Tue, 24 Jun 2025
DSS, Inc.’s Subsidiary, Impact BioMedical Inc., Announces Strategic Merger - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
AMEX
Sector:
Consumer Cyclical
Industry:
Packaging & Containers
Shares Out 0 (M)
Shares Float 0 (M)
Held by Insiders 0 (%)
Held by Institutions 0 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS 0
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) 0 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio 0
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow 0
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android